US Broker Ratings

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant with a 17% Potential Upside

For investors seeking a stable yet promising player in the healthcare sector, Stryker Corporation (NYSE: SYK) presents a compelling opportunity. As a leading entity in the..

Gilead Sciences, Inc. (GILD) Stock Analysis: Unveiling a 21.81% Potential Upside for Investors

Investors eyeing Gilead Sciences, Inc. (NASDAQ: GILD) may find themselves intrigued by the stock’s current positioning within the healthcare sector, particularly the drug manufacturing industry. With..

Eli Lilly (LLY) Stock Analysis: Uncovering Growth Potential in the Healthcare Behemoth

Eli Lilly and Company (NYSE: LLY) stands as a formidable force in the healthcare sector, boasting a staggering market capitalization of $1.07 trillion. This pharmaceutical giant,..

Standard BioTools Inc. (LAB) Stock Analysis: Is a 77% Upside Within Reach?

Standard BioTools Inc. (NASDAQ: LAB), a key player in the medical devices sector, is drawing attention from investors with a noteworthy potential upside of 77.08%. As..

Kamada Ltd. (KMDA) Stock Analysis: Exploring an 86.78% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents a compelling case with its robust product portfolio and significant potential upside. The..

Celcuity Inc. (CELC) Investor Outlook: Analyzing an 85% Upside Potential in the Biotech Sector

Celcuity Inc. (NASDAQ: CELC) is capturing the attention of investors with its promising potential upside of 85%, as indicated by current analyst ratings. As a clinical-stage..

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 235% Potential Upside

Inventiva S.A. – American Depositary Shares (IVA) is catching the eye of the investment community, especially considering its massive potential upside of 235.38%. This French biotechnology..

Abivax SA (ABVX): Investor Outlook on a Biotech with 23% Potential Upside

Abivax SA (ABVX), a French biotechnology company, is capturing investor attention with its innovative approach to treating chronic inflammatory diseases. With a market capitalization of $11.43..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring the 170% Upside Potential in Biotech Innovation

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a prominent player in the biotechnology sector, is stirring considerable interest among investors with its potential for substantial upside. With a..

Auna SA (AUNA)

⚠️ No article content returned.

..

Oruka Therapeutics, Inc. (ORKA): Investor Outlook on a Biotech with 61% Potential Upside

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a Menlo Park-based clinical-stage biopharmaceutical company, has recently captured the attention of investors, thanks to an impressive potential upside of 61.14%...

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 60% Upside Potential Amidst Revenue Challenges

Emergent BioSolutions Inc. (NYSE: EBS) presents a compelling case for investors willing to navigate the complexities of the healthcare sector, particularly in the specialized arena of..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 167% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a prominent player in the biotechnology sector, has garnered significant attention from investors due to its promising therapeutic innovations and substantial..

EyePoint, Inc. (EYPT) Stock Analysis: Unveiling a 223% Upside with Innovative Retinal Therapies

EyePoint, Inc. (EYPT), a biotechnology company rooted in the healthcare sector, is making significant strides in the treatment of serious retinal diseases. With a market capitalization..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: 68.73% Potential Upside Captivates Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company specializing in precision medicines, is making waves in the healthcare sector with its innovative approach to drug..

Delcath Systems (DCTH): Analyst Consensus and 73% Potential Upside Drive Investor Interest

Delcath Systems, Inc. (NASDAQ: DCTH) has caught the eye of investors with a compelling narrative centered around its innovative medical solutions and promising market potential. Operating..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a 34.82% Upside Potential in Biotechnology

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology sector with its focused approach on developing precision therapies for genetically defined diseases. With a..

Prothena Corporation (PRTA) Stock Analysis: Exploring the 150% Upside Potential in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA) is generating buzz in the biotechnology sector, boasting a compelling 150.88% potential upside, according to the latest analyst ratings. As a..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a Potential -37% Downside Amidst Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, stands at an intriguing juncture for investors...

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a 34.45% Potential Upside in the Biotech Sector

For investors eyeing opportunities in the healthcare sector, Septerna, Inc. (SEPN) presents a compelling case with its strong growth potential and promising pipeline. This clinical-stage biotechnology..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds